1987
DOI: 10.1128/jcm.25.9.1629-1634.1987
|View full text |Cite
|
Sign up to set email alerts
|

Production of monoclonal antibodies to Naegleria fowleri, agent of primary amebic meningoencephalitis

Abstract: Monoclonal antibodies (MAbs) to Naegleria fowleri, the etiologic agent of primary amebic meningoencephalitis (PAM), have been produced and used as probes to identify N. fowleri amebae in brain sections of patients who died of that disease. These MAbs were characterized for their specificity by the indirect immunofluorescence assay (IIF), dot immunobinding assay (DIBA), and enzyme-linked immunotransfer blot technique (EITB). The MAbs reacted intensely with all strains of N. fowleri tested originating from diffe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
19
0

Year Published

1993
1993
2017
2017

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 48 publications
(20 citation statements)
references
References 20 publications
(16 reference statements)
1
19
0
Order By: Relevance
“…Based on Western immunoblotting analysis of the pathogenic strain-specific antigen recognized by the MAb developed by Tachibana et al [26], a 30-kDa antigen was described as a marker of pathogenic strains of E. histolytica. The intraspecific differences in the reactivity pattern of NICED 11 also suggest the existence of intraspecific antigenic dissimilarities between strains as has been documented for the esterase enzymes of Naegleria fowleri, an agent of primary amoebic meningoencephalitis [36]. Similarly, a MAb that can distinguish among isolates of E. histofytica belonging to the same zymodeme has been described [I].…”
Section: Discussionmentioning
confidence: 87%
“…Based on Western immunoblotting analysis of the pathogenic strain-specific antigen recognized by the MAb developed by Tachibana et al [26], a 30-kDa antigen was described as a marker of pathogenic strains of E. histolytica. The intraspecific differences in the reactivity pattern of NICED 11 also suggest the existence of intraspecific antigenic dissimilarities between strains as has been documented for the esterase enzymes of Naegleria fowleri, an agent of primary amoebic meningoencephalitis [36]. Similarly, a MAb that can distinguish among isolates of E. histofytica belonging to the same zymodeme has been described [I].…”
Section: Discussionmentioning
confidence: 87%
“…Further identification is needed to distinguish between N. fowleri and other nonhuman pathogenic species. A number of researchers have added additional steps to improve recovery, detection, and identification of N. fowleri, including the use of immunofluorescent antibody assays (Behets et al, 2003;Sparagano et al, 1993;Visvesvara et al, 1987).…”
Section: Methods For Detection Of N Fowleri In Water and Environmentmentioning
confidence: 99%
“…Biochemical techniques such as isoenzyme analysis have been developed for the specific identification of N. fowleri amoebae cultured from the CSF and brain specimens of patients as well as from the environment (water and soil) (Visvesvara & Healy, 1980;De Jonckheere, 1982;Moss et al, 1988). Furthermore, monoclonal antibodies (MAb) that can specifically identify N. fowleri in the CSF have also been developed (Visvesvara et al, 1987). More recently, molecular techniques such as PCR and nested PCR assays for the specific identification of N. fowleri in cultured amoebae from patients and the environment as well as of N. fowleri DNA in the environment have been developed (Réveiller et al, 2002;Zhou et al, 2003;Cogo et al, 2004;De Jonckheere, 2004).…”
Section: Molecular Techniquesmentioning
confidence: 99%